Drug-labels.com

M-Valsartan (Mantra Pharma, 40 mg, 80 mg, 160 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
80 mg, 40 mg, 160 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - M-Valsartan (Mantra Pharma, 40 mg, 80 mg, 160 mg)

What the medication is used for:

High blood pressure (hypertension):

M-VALSARTAN lowers high blood pressure.

Following a heart attack (myocardial infarction):

M-VALSARTAN is used to treat people after a heart attack when an angiotensin-converting enzyme (ACE) inhibitor, considered part of standard therapy for this condition, is not appropriate.

Chronic heart failure:

M-VALSARTAN is used in patients with chronic heart failure, when they are unable to tolerate the standard treatment with medications called ACE inhibitors. There is no evidence that M-VALSARTAN provides added benefit when it is used with ACE inhibitors.

What it does:

M-VALSARTAN is an angiotensin receptor blocker (ARB). You can recognize an ARB because its medicinal ingredient ends in “-SARTAN”.

This medicine does not cure your disease. It helps to control it. Therefore, it is important to continue taking M-VALSARTAN regularly even if you feel fine.

When it should not be used:

Do not take M-VALSARTAN if you:

  • Are allergic to valsartan or to any non-medicinal

    ingredient in the formulation.

  • Have experienced an allergic reaction (angioedema) with

    swelling of the hands, feet, or ankles, face, lips, tongue, throat, or sudden difficulty breathing or swallowing, to any ARB. Be sure to tell your doctor, nurse, or pharmacist that this has happened to you.

  • Are taking a medicine that contains aliskiren (such as

    Rasilez) and you have diabetes or kidney disease.

  • Are pregnant or intend to become pregnant. Taking M-

    VALSARTAN during pregnancy can cause injury and even death to your baby.

  • Are breastfeeding. It is possible that valsartan passes into

    breast milk.

What the medicinal ingredient is:

Valsartan

What the nonmedicinal ingredients are

M-VALSARTAN also contains the following non-medicinal ingredients: crospovidone, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, silica colloidal anhydrous, talc and titanium dioxide.

Additionally, the 40 mg contains iron oxide yellow; the 80 mg iron oxide black and iron oxide red; and the 160 mg iron oxide red and iron oxide yellow.

What dosage forms it comes in:

Tablets: 40 mg, 80 mg, and 160 mg.

Serious Warnings and Precautions - Pregnancy M-VALSARTAN should not be used during pregnancy. If you discover that you are pregnant while taking M-VALSARTAN, stop the medication and contact your doctor, nurse, or pharmacist as soon as possible.

BEFORE you use M-VALSARTAN talk to your doctor, nurse or pharmacist if you:

  • Have experienced an allergic reaction to any drug, including drugs used to lower blood pressure, such as angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB).
  • Have narrowing of an artery or a heart valve.
  • Have had a heart attack or stroke.
  • Have heart failure.
  • Have diabetes, liver or kidney disease.
  • Are on dialysis.
  • Are dehydrated or suffer from excessive vomiting, diarrhea, or sweating.
  • Are taking a salt substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill” that makes your body keep potassium).
  • Are on a low-salt diet.
  • Are taking a medicine that contains aliskiren, such as

    Rasilez, used to lower high blood pressure. The combination with is not recommended.

  • Are taking an angiotensin converting enzyme (ACE)

    inhibitor.

  • Are less than 18 years old,

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to M-VALSARTAN. Dizziness, lightheadedness, or fainting can especially occur after the first dose and when the dose is increased.

INTERACTIONS WITH THIS MEDICATION

ABOUT THIS MEDICATION

WARNINGS AND PRECAUTIONS

IMPORTANT:PLEASE READ

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with M-VALSARTAN:

  • Agents increasing serum potassium, such as a salt

    substitute that contains potassium, potassium supplements, a potassium-sparing diuretic (a specific kind of “water pill”) or other drugs that may increase potassium levels.

  • Lithium, a medicine used to treat some types of

    psychiatric illness such as bipolar disease.

  • Nonsteroidal anti-inflammatory drugs (NSAIDs),

    used to reduce pain and swelling. Examples include ibuprofen, naproxen, and celecoxib.

  • Other blood pressure lowering drugs, including

    diuretics (“water pills”), ACE inhibitors or aliskiren.

  • Rifampin an antibiotic
  • cyclosporine a drug used to protect against transplant

    rejection

  • ritonavir a antiretroviral drug used to treat HIV/AIDS

    infection

PROPER USE OF THIS MEDICATION

Take M-VALSARTAN exactly as prescribed. Swallow M-VALSARTAN tablets with a glass of water. It is recommended to take your dose at about the same time everyday preferably in the morning. You can take M-VALSARTAN with or without food, but it should be taken the same way each day. Do not exceed the recommended dose.

Usual Adult Dose:

High blood pressure (hypertension):

Recommended Initial dose: 80 mg once a day. Dose should be increased gradually.

Maximum dose: 320 mg a day

Following a heart attack (myocardial infarction):

Recommended starting dose: 20 mg twice a day Dose can be increased gradually.

Target maintenance dose: 160 mg twice a day

Chronic heart failure:

Recommended starting dose: 40 mg twice a day. Dose should be increased gradually.

Maximum dose: 160 mg twice a day

Overdose:

If you think you, or a person you are caring for, have taken too much M-VALSARTAN, a healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

  • Dizziness, light headedness,
  • drowsiness,
  • rash,
  • diarrhea, vomiting, nausea,
  • headache,
  • back or leg pain, muscle cramps,
  • Muscle pain, muscle weakness,
  • Unusual tiredness, weakness,
  • Cough,
  • Impotence,
  • Nosebleed
  • Blistering skin (sign of dermatitis bullous)

If any of these affects you severely, tell your doctor, nurse or pharmacist healthcare professional.

M-VALSARTAN can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT
THEM
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Common

Allergic

reactions: Skin rash, skin eruption or other effect on the skin or eyes

√

Increased levels of potassium in the blood:

irregular

heartbeats, muscle weakness and generally feeling unwell

√
Uncommon

Low blood pressure

(hypotension):

dizziness,

fainting,

lightheadedness May occur when you go from lying or sitting to standing up

√
IMPORTANT:PLEASE READ
SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT
THEM

Symptom / effect

Angioedema/

Allergic

reactions: rash, hives, swelling of the lips, face or neck, tongue or throat

accompanied by difficulty in

breathing,

swallowing or speaking,

Kidney Disorder:

change in

frequency of

urination, nausea, vomiting, swelling of extremities, fatigue

Liver Disorder:

yellowing of the skin or eyes, dark urine, abdominal pain, nausea,

vomiting, loss of appetite

Rhabdomyolysis:

muscle pain that you cannot

explain, muscle tenderness or weakness, dark brown urine.

Abdominal pain

Talk to your healthcare professional

Stop taking drug and

get

immediate medical help

Only if severeIn all cases
√
√
√
√
√

Cardiac failure:

breathlessness, difficulty

breathing when lying down,

swelling of the feet or legs

√

Vasculitis:

Inflammation of blood vessels purplished-red spots, fever, itching

√

Decreased

Platelets:

bruising, unusual bleeding, fatigue and weakness

√
Anemia: fatigue, loss of energy, weakness,√
SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT
THEM

Symptom / effect

shortness of

breath

Decreased White Blood Cells:

infections, fatigue, fever, aches,

pains, and flu-like symptoms, sore throat or mouth ulcers

Insomnia

Flu like

symptoms, joint pain, pharyngitis, inflammation of sinuses, runny or stuffy nose,

swollen hands, ankles or feet, upper respiratory tract infection, viral infection Palpitations:

irregular

heartbeats

Talk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
√
√
√
√
UnknownChange in libido√

Blistering skin reactions with symptoms such as rash, red skin, blistering of the lips, eyes or

mouth, skin

peeling and fever

√

This is not a complete list of side effects. For any unexpected effects while taking M-VALSARTAN, contact your doctor, nurse or pharmacist.

HOW TO STORE IT

Do not use M-VALSARTAN past the expiry date shown on the pack.

Protect from moisture and heat (store at 15°C - 30° C).

Keep this medicine out of the reach and sight of children.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting

    (https://www.canada.ca/en/health-canada/services/drugs-

IMPORTANT:PLEASE READ

health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about M-VALSARTAN:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs- health-products/drug-products/drug-product- database.html) or by contacting Mantra Pharma Inc, at medinfo@mantrapharma.ca or at 1-833-248-7326.

Mantra Pharma Inc.

Brossard, Quebec

Canada J4Y 0E3

Last revised: January 18, 2022

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02524538

Revision date stated in the text: January 18, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for M-Valsartan (Mantra Pharma, 40 mg, 80 mg, 160 mg)

Rx or OTC
Prescription (Rx)?
DIN 02524538, 02524511, 02524546
Schedule(s) PRESCRIPTION
Active ingredient(s) Valsartan
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA03 Valsartan
Company MANTRA PHARMA INC
Current status Cancelled Post Market
Strengths and forms
DIN Strength Dosage form(s) Current status
02524538 80 MG Tablet Cancelled Post Market September 10, 2025
02524511 40 MG Tablet Cancelled Post Market July 8, 2024
02524546 160 MG Tablet Cancelled Post Market February 25, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.